Published in Nat Immunol on June 27, 2010
MR1 presents microbial vitamin B metabolites to MAIT cells. Nature (2012) 3.71
Logical development of the cell ontology. BMC Bioinformatics (2011) 3.68
The burgeoning family of unconventional T cells. Nat Immunol (2015) 2.70
Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. J Exp Med (2011) 2.30
Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells. J Exp Med (2013) 2.04
Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol (2013) 1.93
CD161++ CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner. Eur J Immunol (2013) 1.72
Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor. J Exp Med (2012) 1.71
Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection. Infect Immun (2012) 1.69
Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood (2012) 1.69
Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases. Clin Exp Immunol (2014) 1.66
Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection. Blood (2012) 1.60
MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection. Proc Natl Acad Sci U S A (2013) 1.54
A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells. J Exp Med (2014) 1.50
MR1-restricted MAIT cells display ligand discrimination and pathogen selectivity through distinct T cell receptor usage. J Exp Med (2014) 1.49
Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1. J Hepatol (2015) 1.47
Endogenous MHC-related protein 1 is transiently expressed on the plasma membrane in a conformation that activates mucosal-associated invariant T cells. J Immunol (2011) 1.47
In search of a new paradigm for protective immunity to TB. Nat Rev Microbiol (2014) 1.39
The evolution of cellular deficiency in GATA2 mutation. Blood (2013) 1.36
Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells. Immunol Rev (2014) 1.33
MAIT cells detect and efficiently lyse bacterially-infected epithelial cells. PLoS Pathog (2013) 1.32
Co-dependents: MR1-restricted MAIT cells and their antimicrobial function. Nat Rev Microbiol (2012) 1.30
Human thymic MR1-restricted MAIT cells are innate pathogen-reactive effectors that adapt following thymic egress. Mucosal Immunol (2012) 1.29
CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages. Cell Rep (2014) 1.28
Acquisition of innate-like microbial reactivity in mucosal tissues during human fetal MAIT-cell development. Nat Commun (2014) 1.21
The molecular basis for Mucosal-Associated Invariant T cell recognition of MR1 proteins. Proc Natl Acad Sci U S A (2013) 1.21
IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations. Science (2015) 1.19
Mucosal-associated invariant T-cells: new players in anti-bacterial immunity. Front Immunol (2014) 1.19
Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161(hi) CD8α⁺ semi-invariant T cells. Blood (2011) 1.16
Requirements for eomesodermin and promyelocytic leukemia zinc finger in the development of innate-like CD8+ T cells. J Immunol (2011) 1.16
Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients. J Clin Invest (2015) 1.15
MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets. Mucosal Immunol (2014) 1.13
Exceptionally high conservation of the MHC class I-related gene, MR1, among mammals. Immunogenetics (2012) 1.10
Cellular response to mycobacteria: balancing protection and pathology. Trends Immunol (2011) 1.10
Hallmarks of Tissue-Resident Lymphocytes. Cell (2016) 1.10
Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver. PLoS Pathog (2014) 1.09
Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers. J Exp Med (2015) 1.09
Mucus clearance, MyD88-dependent and MyD88-independent immunity modulate lung susceptibility to spontaneous bacterial infection and inflammation. Mucosal Immunol (2012) 1.09
Lipid and small-molecule display by CD1 and MR1. Nat Rev Immunol (2015) 1.07
Low levels of peripheral CD161++CD8+ mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection. PLoS One (2013) 1.06
CD161-expressing human T cells. Front Immunol (2011) 1.05
MAIT recognition of a stimulatory bacterial antigen bound to MR1. J Immunol (2013) 1.04
Genetically retargeting CD8+ lymphocyte subsets for cancer immunotherapy. Curr Opin Immunol (2011) 1.04
Cernunnos deficiency reduces thymocyte life span and alters the T cell repertoire in mice and humans. Mol Cell Biol (2012) 1.04
Check MAIT. J Immunol (2014) 1.03
MAIT cell recognition of MR1 on bacterially infected and uninfected cells. PLoS One (2013) 1.02
Nonconventional CD8+ T cell responses to Listeria infection in mice lacking MHC class Ia and H2-M3. J Immunol (2010) 1.00
B cells modulate mucosal associated invariant T cell immune responses. Front Immunol (2014) 0.99
Structure of a classical MHC class I molecule that binds "non-classical" ligands. PLoS Biol (2010) 0.98
The IL-17A-producing CD8+ T-cell population in psoriatic lesional skin comprises mucosa-associated invariant T cells and conventional T cells. J Invest Dermatol (2014) 0.96
Will loss of your MAITs weaken your HAART [corrected]? AIDS (2013) 0.96
Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites. J Immunol (2015) 0.96
A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage. Nat Immunol (2016) 0.94
Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. PLoS Pathog (2015) 0.94
Circulating mucosal associated invariant T cells are activated in Vibrio cholerae O1 infection and associated with lipopolysaccharide antibody responses. PLoS Negl Trop Dis (2014) 0.94
Microbes, the gut and ankylosing spondylitis. Arthritis Res Ther (2013) 0.93
Nonclassical MHC class I-dependent invariant T cells are evolutionarily conserved and prominent from early development in amphibians. Proc Natl Acad Sci U S A (2013) 0.93
Protection versus pathology in tuberculosis: recent insights. Curr Opin Immunol (2012) 0.92
Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals. Mucosal Immunol (2016) 0.92
Reduced mucosal associated invariant T-cells are associated with increased disease severity and Pseudomonas aeruginosa infection in cystic fibrosis. PLoS One (2014) 0.92
CD8 T cells and Mycobacterium tuberculosis infection. Semin Immunopathol (2015) 0.91
Early initiation of combined antiretroviral therapy preserves immune function in the gut of HIV-infected patients. Mucosal Immunol (2014) 0.91
High expression of CD26 accurately identifies human bacteria-reactive MR1-restricted MAIT cells. Immunology (2015) 0.91
Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol (2014) 0.91
γδ T cell receptor ligands and modes of antigen recognition. Arch Immunol Ther Exp (Warsz) (2011) 0.91
The Role of Mucosal Associated Invariant T Cells in Antimicrobial Immunity. Front Immunol (2015) 0.90
Role of Innate T Cells in Anti-Bacterial Immunity. Front Immunol (2015) 0.90
MR1-restricted mucosal associated invariant T (MAIT) cells in the immune response to Mycobacterium tuberculosis. Immunol Rev (2015) 0.89
Fighting infection with your MAITs. Nat Immunol (2010) 0.89
αβ T-cell receptors from multiple sclerosis brain lesions show MAIT cell-related features. Neurol Neuroimmunol Neuroinflamm (2015) 0.88
Recognition of Vitamin B Precursors and Byproducts by Mucosal Associated Invariant T Cells. J Biol Chem (2015) 0.87
CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression. PLoS One (2014) 0.87
Mucosal-associated invariant T cell-rich congenic mouse strain allows functional evaluation. J Clin Invest (2015) 0.87
Transcription factor networks directing the development, function, and evolution of innate lymphoid effectors. Annu Rev Immunol (2015) 0.87
The intracellular pathway for the presentation of vitamin B-related antigens by the antigen-presenting molecule MR1. Nat Immunol (2016) 0.87
MAIT cells are activated during human viral infections. Nat Commun (2016) 0.86
Diverse roles of non-diverse molecules: MHC class Ib molecules in host defense and control of autoimmunity. Curr Opin Immunol (2010) 0.86
CD1 and mycobacterial lipids activate human T cells. Immunol Rev (2015) 0.86
Salmonella Typhi-specific multifunctional CD8+ T cells play a dominant role in protection from typhoid fever in humans. J Transl Med (2016) 0.86
Involvement of CD8(+) T Cells in Multiple Sclerosis. Front Immunol (2015) 0.85
Attrition of TCR Vα7.2+ CD161++ MAIT cells in HIV-tuberculosis co-infection is associated with elevated levels of PD-1 expression. PLoS One (2015) 0.85
Unusual evolutionary conservation and further species-specific adaptations of a large family of nonclassical MHC class Ib genes across different degrees of genome ploidy in the amphibian subfamily Xenopodinae. Immunogenetics (2014) 0.83
The T cell antigen receptor: the Swiss army knife of the immune system. Clin Exp Immunol (2015) 0.82
Human TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT riboflavin-based antigens. Nat Commun (2016) 0.82
Mucosa-Associated Invariant T Cells Are Systemically Depleted in Simian Immunodeficiency Virus-Infected Rhesus Macaques. J Virol (2016) 0.82
Role of non-conventional T lymphocytes in respiratory infections: the case of the pneumococcus. PLoS Pathog (2014) 0.81
Deficiencies of Circulating Mucosal-associated Invariant T Cells and Natural Killer T Cells in Patients with Acute Cholecystitis. J Korean Med Sci (2015) 0.81
Mucosal associated invariant T cells and the immune response to infection. Microbes Infect (2011) 0.81
Altered CD161 bright CD8+ mucosal associated invariant T (MAIT)-like cell dynamics and increased differentiation states among juvenile type 1 diabetics. PLoS One (2015) 0.81
NKp46+ CD3+ cells: a novel nonconventional T cell subset in cattle exhibiting both NK cell and T cell features. J Immunol (2014) 0.81
CD1d- and MR1-Restricted T Cells in Sepsis. Front Immunol (2015) 0.81
Nonclassical MHC-Restricted Invariant Vα6 T Cells Are Critical for Efficient Early Innate Antiviral Immunity in the Amphibian Xenopus laevis. J Immunol (2015) 0.81
MR1-restricted mucosal-associated invariant T (MAIT) cells respond to mycobacterial vaccination and infection in nonhuman primates. Mucosal Immunol (2016) 0.81
Evolution of nonclassical MHC-dependent invariant T cells. Cell Mol Life Sci (2014) 0.80
Role of circulating lymphocytes in patients with sepsis. Biomed Res Int (2014) 0.80
Mucosal-Associated Invariant T Cells in Multiple Sclerosis: The Jury is Still Out. Front Immunol (2015) 0.80
Endosomal MR1 Trafficking Plays a Key Role in Presentation of Mycobacterium tuberculosis Ligands to MAIT Cells. PLoS Pathog (2016) 0.80
MR1-Restricted Mucosal-Associated Invariant T Cells and Their Activation during Infectious Diseases. Front Immunol (2015) 0.80
Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature (2006) 24.43
Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell (2005) 20.30
Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell (2009) 20.29
Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity (1998) 18.12
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature (2005) 17.47
An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell (2005) 15.46
The biology of NKT cells. Annu Rev Immunol (2007) 14.43
VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell (2005) 14.20
Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature (2003) 10.97
Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem (2003) 10.79
TLR signaling. Cell Death Differ (2006) 9.24
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature (2008) 9.16
The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity (2009) 8.95
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ (2007) 8.85
TLR signaling. Semin Immunol (2007) 8.16
Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature (2005) 7.72
Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science (2003) 7.49
Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J Biol Chem (2006) 5.92
Nod-like proteins in immunity, inflammation and disease. Nat Immunol (2006) 5.25
Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature (2003) 3.87
Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J Biol Chem (1999) 3.53
An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals. J Exp Med (1999) 3.20
Stepwise development of MAIT cells in mouse and human. PLoS Biol (2009) 3.18
Autoreactivity by design: innate B and T lymphocytes. Nat Rev Immunol (2001) 3.08
Immunoregulation in the tissues by gammadelta T cells. Nat Rev Immunol (2003) 2.80
IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men. Curr Opin Immunol (1999) 2.69
Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity (2007) 2.58
Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity (2007) 2.15
MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution. Proc Natl Acad Sci U S A (2009) 1.81
Invariant V(alpha)19i T cells regulate autoimmune inflammation. Nat Immunol (2006) 1.72
Identification of an H2-M3-restricted Listeria epitope: implications for antigen presentation by M3. Immunity (1996) 1.70
Genomics, isoforms, expression, and phylogeny of the MHC class I-related MR1 gene. J Immunol (1998) 1.69
MR1-restricted V alpha 19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response. J Immunol (2006) 1.69
Modulation of Valpha19 NKT cell immune responses by alpha-mannosyl ceramide derivatives consisting of a series of modified sphingosines. Eur J Immunol (2007) 1.68
MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells. J Exp Med (2008) 1.67
Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells. J Exp Med (2005) 1.59
The importance of Toll-like receptor 2 polymorphisms in severe infections. Clin Infect Dis (2005) 1.57
New perspectives in B-1 B cell development and function. Trends Immunol (2006) 1.42
A Listeria monocytogenes pentapeptide is presented to cytolytic T lymphocytes by the H2-M3 MHC class Ib molecule. Immunity (1996) 1.41
Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice. Infect Immun (2007) 1.34
Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway. Cell Mol Biol (Noisy-le-grand) (2006) 1.33
Innate-like B cells. Springer Semin Immunopathol (2005) 1.24
Differential alteration of lipid antigen presentation to NKT cells due to imbalances in lipid metabolism. Eur J Immunol (2007) 1.19
Dendritic cells pulsed with exogenous hepatitis B surface antigen particles efficiently present epitopes to MHC class I-restricted cytotoxic T cells. Eur J Immunol (2002) 0.95
Toll-like receptor-dependent discrimination of streptococci. J Endotoxin Res (2006) 0.89
TLR9 activation increases TAP-independent vesicular MHC class I processing in vivo. Scand J Immunol (2009) 0.84
Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science (2003) 4.80
The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity (2008) 4.68
Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature (2003) 3.87
Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol (2002) 3.78
Non mycobacterial virulence genes in the genome of the emerging pathogen Mycobacterium abscessus. PLoS One (2009) 3.53
Stepwise development of MAIT cells in mouse and human. PLoS Biol (2009) 3.18
Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol (2010) 3.15
Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res (2005) 3.12
Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood (2010) 3.06
CD4 cells can be more efficient at tumor rejection than CD8 cells. Blood (2007) 2.68
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. J Transl Med (2005) 2.33
Cross-primed CD8(+) T cells mediate graft rejection via a distinct effector pathway. Nat Immunol (2002) 2.25
Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure. Proc Natl Acad Sci U S A (2005) 2.04
Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france. J Clin Microbiol (2009) 2.03
Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive Care Med (2013) 2.02
Mucosal-associated invariant T cells: unconventional development and function. Trends Immunol (2011) 2.01
Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nat Genet (2005) 1.99
Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells. Blood (2011) 1.83
MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution. Proc Natl Acad Sci U S A (2009) 1.81
CD1d- and MR1-restricted invariant T cells: of mice and men. Curr Opin Immunol (2006) 1.77
Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease. PLoS Genet (2006) 1.74
Evidence for MR1 antigen presentation to mucosal-associated invariant T cells. J Biol Chem (2005) 1.72
Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet (2001) 1.70
Outer membrane proteins: key players for bacterial adaptation in host niches. Microbes Infect (2002) 1.68
MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells. J Exp Med (2008) 1.67
gamma(c) cytokines provide multiple homeostatic signals to naive CD4(+) T cells. Eur J Immunol (2007) 1.55
Dendritic cell maturation controls adhesion, synapse formation, and the duration of the interactions with naive T lymphocytes. J Immunol (2004) 1.49
Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients. AIDS (2011) 1.47
Endogenous MHC-related protein 1 is transiently expressed on the plasma membrane in a conformation that activates mucosal-associated invariant T cells. J Immunol (2011) 1.47
Extrathymic induction of Foxp3⁺ regulatory T cells declines with age in a T-cell intrinsic manner. Eur J Immunol (2013) 1.45
Dendritic cell-derived exosomes for cancer immunotherapy: what's next? Cancer Res (2010) 1.43
Establishment and characterization of a panel of human uveal melanoma xenografts derived from primary and/or metastatic tumors. Clin Cancer Res (2010) 1.42
Mucosal-associated invariant T (MAIT) cells: an evolutionarily conserved T cell subset. Microbes Infect (2005) 1.40
Effect of Campylobacter-specific maternal antibodies on Campylobacter jejuni colonization in young chickens. Appl Environ Microbiol (2003) 1.39
Effect of conventional and organic production practices on the prevalence and antimicrobial resistance of Campylobacter spp. in poultry. Appl Environ Microbiol (2006) 1.35
Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice. Infect Immun (2007) 1.34
Are major histocompatibility complex molecules involved in the survival of naive CD4+ T cells? J Exp Med (2003) 1.34
Severe combined immunodeficiency caused by deficiency in either the delta or the epsilon subunit of CD3. J Clin Invest (2004) 1.33
Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis. Int Immunol (2011) 1.33
MAIT cells detect and efficiently lyse bacterially-infected epithelial cells. PLoS Pathog (2013) 1.32
Patterns of nonclassical MHC antigen presentation. Nat Immunol (2007) 1.32
MAIT cells, surveyors of a new class of antigen: development and functions. Curr Opin Immunol (2013) 1.30
Robustness of two MALDI-TOF mass spectrometry systems for bacterial identification. J Microbiol Methods (2012) 1.28
Risk of tumorigenicity in mesenchymal stromal cell-based therapies--bridging scientific observations and regulatory viewpoints. Cytotherapy (2013) 1.27
Molecular study of microsporidiosis due to Enterocytozoon bieneusi and Encephalitozoon intestinalis among human immunodeficiency virus-infected patients from two geographical areas: Niamey, Niger, and Hanoi, Vietnam. J Clin Microbiol (2007) 1.27
HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis. Blood (2011) 1.25
Annexin II incorporated into influenza virus particles supports virus replication by converting plasminogen into plasmin. J Virol (2008) 1.23
Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway. J Immunol (2009) 1.19
CD1c tetramers detect ex vivo T cell responses to processed phosphomycoketide antigens. J Exp Med (2013) 1.16
Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients. J Clin Invest (2015) 1.15
Acute respiratory failure involving an R variant of Mycobacterium abscessus. J Clin Microbiol (2008) 1.12
Management of travelers with fever and exanthema, notably dengue and chikungunya infections. Am J Trop Med Hyg (2008) 1.12
Expansion of functional human mucosal-associated invariant T cells via reprogramming to pluripotency and redifferentiation. Cell Stem Cell (2013) 1.11
Skin carcinoma arising from donor cells in a kidney transplant recipient. Cancer Res (2005) 1.06
Double-positive thymocytes select mucosal-associated invariant T cells. J Immunol (2013) 1.05
Spread of a Klebsiella pneumoniae strain producing a plasmid-mediated ACC-1 AmpC beta-lactamase in a teaching hospital admitting disabled patients. Antimicrob Agents Chemother (2005) 1.04
IFN-gamma mediates the rejection of haematopoietic stem cells in IFN-gammaR1-deficient hosts. PLoS Med (2008) 1.04
Antigen-specific T-T interactions regulate CD4 T-cell expansion. Blood (2008) 1.04
Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma. Int J Cancer (2013) 1.03
Updated technology to produce highly immunogenic dendritic cell-derived exosomes of clinical grade: a critical role of interferon-γ. J Immunother (2011) 1.03
Mutant mice lacking the p53 C-terminal domain model telomere syndromes. Cell Rep (2013) 1.02
MAIT cell recognition of MR1 on bacterially infected and uninfected cells. PLoS One (2013) 1.02
Expansion and function of CD8+ T cells expressing Ly49 inhibitory receptors specific for MHC class I molecules. J Immunol (2004) 1.02
Matrix metalloproteinase gene polymorphisms and bronchopulmonary dysplasia: identification of MMP16 as a new player in lung development. PLoS One (2008) 1.01
Overexpression of proinflammatory TLR-2-signalling lipoproteins in hypervirulent mycobacterial variants. Cell Microbiol (2011) 1.01
Specific distribution within the Enterobacter cloacae complex of strains isolated from infected orthopedic implants. J Clin Microbiol (2009) 1.01
Whole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation. J Allergy Clin Immunol (2013) 1.00
Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis. PLoS Pathog (2013) 1.00
In vivo neuronal tracing with GFP-TTC gene delivery. Mol Cell Neurosci (2002) 1.00
PAR1 contributes to influenza A virus pathogenicity in mice. J Clin Invest (2012) 1.00
Feto-maternal microchimerism in connective tissue diseases. Eur J Immunol (2002) 0.99
Human iNKT and MAIT cells exhibit a PLZF-dependent proapoptotic propensity that is counterbalanced by XIAP. Blood (2012) 0.97